Dermatology

Medicine & Life Sciences

1. Squamous Cell Carcinoma 100%
2. Skin Neoplasms 97%
3. Skin 85%
4. Mohs Surgery 51%
5. Skin Pigmentation 38%
6. Transcriptome 37%
7. Neoplasm Metastasis 37%
8. Dermatology 36%
9. Melanoma 35%
10. Cohort Studies 31%
11. Neoplasms 29%
12. Prospective Studies 28%
13. Dermatologic Surgical Procedures 25%
14. Hispanic Americans 24%
15. Basal Cell Carcinoma 23%
16. Becker Nevus Syndrome 21%
17. Dermatologists 21%
18. Gene Expression Profiling 21%
19. High-Throughput Nucleotide Sequencing 19%
20. African Americans 19%
21. Mutation 18%
22. Immunocompromised Host 18%
23. lavender oil 17%
24. Systematic Reviews 17%
25. Ecthyma 17%
26. Young Adult 16%
27. Nose 16%
28. Moraxella 16%
29. Dermal Fillers 16%
30. INCB018424 15%
31. Acitretin 15%
32. Dermatofibrosarcoma 14%
33. Culex 14%
34. Lymph Nodes 14%
35. Nasal Surgical Procedures 14%
36. Merkel Cell Carcinoma 14%
37. Patient Care 13%
38. West Nile virus 13%
39. Health Personnel 13%
40. Spironolactone 13%
41. Allergic Contact Dermatitis 13%
42. Pandemics 12%
43. Volatile Oils 12%
44. Virtual Reality 12%
45. Population 12%
46. Therapeutics 12%
47. Arsenic 12%
48. Nevus 12%
49. Surgeons 11%
50. Recurrence 11%
51. Squamous Cell Carcinoma of Head and Neck 11%
52. Photochemotherapy 11%
53. Culicidae 10%
54. Risk Assessment 10%
55. Patient Satisfaction 10%
56. PubMed 10%
57. Confidence Intervals 10%
58. Women's Health 10%
59. Head 10%
60. Patient Education 10%
61. Necrosis 10%
62. Hypothyroidism 10%
63. Insurance 10%
64. Biopsy 10%
65. Neck 10%
66. Exanthema 10%
67. Genes 10%
68. Birth Weight 9%
69. Allergens 9%
70. Chemoprevention 9%
71. Wound Healing 8%
72. Postoperative Complications 8%
73. Single Nucleotide Polymorphism 8%
74. Musculoskeletal Abnormalities 8%
75. Quality of Life 8%
76. Therapeutic Uses 8%
77. Inpatients 8%
78. Carcinoma 8%
79. Contact Dermatitis 8%
80. Odds Ratio 7%
81. Retrospective Studies 7%
82. Breast 7%
83. Eating 7%
84. Age Groups 7%
85. Emotions 7%
86. Light 7%
87. Accreditation 7%
88. Immunohistochemistry 7%
89. Physicians 6%
90. Mortality 6%
91. Nose Neoplasms 6%
92. Anti-Bacterial Agents 6%
93. Pediatrics 6%
94. Infections 6%
95. Demography 6%
96. Practice Guidelines 6%
97. Hamartoma 6%
98. Immunosuppression 6%
99. Survival 5%
100. Polyomavirus Infections 5%